Keywords: centeon, begins, largest, worldwide, sepsis, study, planning

Centeon Begins Largest Worldwide Sepsis Study

Article | 17 July 1997

Print This

Centeon is planning to conduct a 2,000-patient Phase III study to assessits antithrombin III product, Kybernin-P, as a treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in